trial

Adapting the Tumor Board Model for Mental Illness and Cancer

NCTId NCT05837598

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

— · Unknown

Enrollment 30 (estimated)

Sponsored by Massachusetts General Hospital

Primary completion 2024-05-31

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Unknown

Enrollment

30 (estimated)

Study type

Interventional

Allocation

Model

Single Group

Masking

None

Start

2023-05-31

Primary completion

2024-05-31

Eligibility

ALL · 18 Years

Interventions & indications

Drugs

Virtual Cancer and Mental Health Tumor Board

Indications

Cancer Head and Neck Cancer Bipolar Disorder Gastrointestinal Neoplasms Schizophrenia Genitourinary Cancer Neoplasms Breast Neoplasms Head and Neck Neoplasms Gastrointestinal Cancer Lung Neoplasms Urogenital Neoplasms

Sites

1 total

Danvers, United States

Facts & assertions

4 sourced

Enrollment

Phase

Primary Completion Date

2024-05-31

Status

UNKNOWN

relationships

The graph out of here

drug

Virtual Cancer and Mental Health Tumor Board

drug

lead_sponsor

Massachusetts General Hospital

company

collaborator

Trefler Foundation

company

indication

Cancer

indication

Head and Neck Cancer

indication

Bipolar Disorder

indication